SAN DIEGO — Fixed-interval dosing with vascular endothelial growth-factor (VEGF) inhibitors might be more effective than as-needed dosing, a new study shows. "It's a safe, effective means of treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results